跳至主要内容
临床试验/CTRI/2024/11/077424
CTRI/2024/11/077424尚未招募4 期

Role of vitamin E and omega 3 fatty acid in management of dysmenorrhea

Teerthanker Mahaveer Medical College and Research Centrea1 个研究点 分布在 1 个国家目标入组 360 人开始时间: 2024年12月9日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
360
试验地点
1
主要终点
Effect on average pain and maximum pain on VAS scale during menstruation in dysmenorrhea patients in 3 groups

研究概览

简要总结

We want to compare the effect of vitamin E and Omega 3 fatty acid on average and maximum pain during menstruation in dysmenorrhea patients. Participants will be enrolled after inclusion and exclusion criteria. Preintervention average pain and maximum pain during menstruation on VAS scale, average menstrual blood flow on PBAC chart and average number of NSAID tablets taken by patient for pain control during menstruation in the preceding last 3 menstrual cycle will be noted..  Participants will be randomized into 3 groups.  Group A will receive 400 IU of vitamin E, group B will receive 600 mg of omega 3 fatty acid and group C will receive both 400 IU of vitamin E and 600 mg of omega 3 fatty acid orally starting from 5 days before the start of menstruation for a total of 8 days for 3 consecutive menstrual  cycles. Postintervention following outcome will be assessed after 1st, 2nd and 3rd month - average and maximum pain during menstruation on VAS scale, menstruation blood flow on PBAC scale and total number of NSAID tablets taken by patient  for pain during menstruation. Any side effects will be noted. appropriate statistical tests will be applied to compare the effects in 3 groups.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Females aged 18 to 45 years coming to Obstetrics and Gynaecology department with the diagnosis of dysmenorrhea.

排除标准

  • Patients with irregular menstrual cycles Patients requiring immediate surgical management Patients requiring immediate hormonal management Patients with active PID Patients with coagulopathy Patients taking opioid analgesic Patients on anticoagulants Patients with liver disease Patients with cardiac disease.

结局指标

主要结局

Effect on average pain and maximum pain on VAS scale during menstruation in dysmenorrhea patients in 3 groups

时间窗: 1 month, 2 months, 3 months

次要结局

  • Total number of NSAID tablets taken during menstruation in dysmenorrhea patients(1 month, 2 months, 3 months)
  • Effect on menstrual blood flow ( PBAC) in three groups(1 month, 2 months, 3 months)

研究者

发起方
Teerthanker Mahaveer Medical College and Research Centrea
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Kanchan Rani

Teerthanker Mahaveer Medical College and Research Centre, Moradabad

研究点 (1)

Loading locations...

相似试验